Ascendant Capital Management’s SPDR S&P Biotech ETF XBI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-12,500	Closed	-$1.04M	–	81
2022 Q4	$1.04M	Buy	+12,500	New	+$1.04M	3.1%	10